Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

Abstract

Treatment with gemcitabine concomitant with radiation therapy according to the present schedule is well tolerated and can provide prolonged CBR and disease stabilization in patients with localized, unresectable pancreatic cancer.